Moderna-Merck gets USFDA Breakthrough Therapy Designation for personalized mRNA cancer vaccine in combination with KEYTRUDA to treat high risk melanoma Ruchika Sharma23 Feb 2023 2:45 PM ISTCambridge: Moderna, Inc. and Merck have announced that mRNA-4157/V940, an investigational personalized mRNA cancer vaccine, in combination with...
LAGEVRI did not demonstrate statistically significant reduction in COVID risk following household exposure to another individual with COVID: Merck Ruchika Sharma23 Feb 2023 9:00 AM ISTRahway: Merck, known as MSD outside the United States and Canada, has announced that LAGEVRI (molnupiravir) did not demonstrate a statistically...
Merck announces positive results from phase 3 KEYNOTE-859 trial of Keytruda plus chemotherapy to treat patients with HER2-negative gastric or GEJ adenocarcinoma Ruchika Sharma20 Feb 2023 2:30 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Merck gets USFDA priority review for PREVYMIS for Prophylaxis of Cytomegalovirus Disease in kidney transplant recipients at high risk Ruchika Sharma19 Feb 2023 4:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has accepted for...
MSD Pharma likely to participate in global tender for procurement of HPV vaccine against cervical cancer Ruchika Sharma16 Feb 2023 11:28 AM ISTThe Union Health Ministry is likely to float a global tender for HPV in April for 16.02 crore doses to be procured by 2026.
Drug companies face COVID cliff in 2023 as sales set to plummet Ruchika Sharma8 Feb 2023 3:27 PM ISTNew York: Pharmaceutical companies that made billions from the pandemic over the past two years selling vaccines and treatments are now up...
USFDA removes COVID test requirements for Merck, Pfizer pills Ruchika Sharma2 Feb 2023 12:15 PM ISTThe health regulator said individuals with recent known exposure with signs and symptoms may be diagnosed by their healthcare providers with COVID...
Merck gets USFDA nod for KEYTRUDA as adjuvant treatment for non-small cell lung cancer Ruchika Sharma30 Jan 2023 2:45 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
ITAT allows Rs 3 crore deduction to Merck, says free samples to doctors recognized under UCPMP not violative of MCI Rules Farhat Nasim24 Jan 2023 7:33 PM ISTMumbai: Allowing a deduction of Rs 3 crore to pharma company Merck Limited, the Mumbai Bench of Income Tax Appellate Tribunal (ITAT) has held that the...
Merck set to remove cancer-causing chemical from top diabetes drugs Ruchika Sharma18 Jan 2023 1:15 PM ISTNew Jersey: Merck & Co has discovered how its blockbuster diabetes drugs have become contaminated with a potential carcinogen and believe it can...
Pfizer, Merck rebuff China's push for deeper price cuts on COVID drugs: Bloomberg MD Bureau13 Jan 2023 3:14 PM ISTDelhi: Top US makers of Covid drugs appear to be pushing back on China's efforts to get them to cut their prices, underscoring the challenges the...
Merck, Antengene collaborate to test Keytruda, ATG-037 combo for solid tumors in phase 1 trial Ruchika Sharma31 Dec 2022 11:30 AM ISTATG-037 is an orally available, small molecule CD73 inhibitor.
